Invesco’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Invesco’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-2,780	Closed	-$122K	–	4310
2013 Q4	$122K	Hold	2,780	–	–	﹤0.01%	3981
2013 Q3	$107K	Hold	2,780	–	–	﹤0.01%	3991
2013 Q2	$98K	Buy	+2,780	New	+$93.8K	﹤0.01%	3959

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Invesco's XPH Position: Q1 2014 in Review

Invesco sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2014, closing a stake of 2,780 shares — an estimated $122K sold.

Invesco first reported a position in XPH in Q2 2013 and held it in 3 quarters. The position peaked at $122K in Q4 2013. 72 funds tracked by Wall St. Rank hold XPH as of Q1 2014.

Invesco reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2014 after selling out during the quarter.
Invesco sold 2,780 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2014, an estimated $122K.
Invesco first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 3 quarters.
Invesco's State Street SPDR S&P Pharmaceuticals ETF position peaked at $122K in Q4 2013.
72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.